CIK 0001626644 · Non-accelerated filer<br>Smaller reporting company
Odyssey Health, Inc.
Sign in to watch- Ticker
- ODYY
- Exchange
- OTC
- Industry
- Surgical & Medical Instruments & Apparatus
- FY end
- Jul 31
- Incorporated
- NV
- Entity type
- operating
- EIN
- 471022125
- Phone
- 702-780-6559
- Business address
- 2300 WEST SAHARA AVENUE, SUITE 800-#4012, LAS VEGAS, NV, 89102
- Former names
- Odyssey Group International, Inc.
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2024-06-28 | FARRELL CHRISTINE Chief Financial Officer | Grant or award · Stock Option (Right to Buy) | +500,000 | $0.10 | $50K | 500,000 |
| 2024-06-28 | RICHARDSON RICKY Director | Grant or award · Stock Option (Right to Buy | +300,000 | $0.10 | $30K | 300,000 |
| 2024-06-28 | Casey Jerome H Director | Grant or award · Stock Option (Right to Buy) | +300,000 | $0.10 | $30K | 300,000 |
| 2024-06-28 | REDMOND J MICHAEL President & CEO | Grant or award · Stock Option (Right to Buy) | +500,000 | $0.10 | $50K | 500,000 |
| 2024-06-28 | Gironda Gregory W Chief Operating Officer | Grant or award · Stock Option (Right to Buy | +250,000 | $0.10 | $25K | 250,000 |
| 2024-01-16 | Gironda Gregory W Chief Operating Officer | Grant or award · Stock Option (Right to Buy) | +37,500 | $0.09 | $3K | 37,500 |
| 2024-01-16 | Emerson Erik C. Chief Commerical Officer | Grant or award · Stock Option (Right to Buy) | +37,500 | $0.09 | $3K | 37,500 |
| 2024-01-10 | GANDOLFO JOHN P Former Director | Grant or award | +1,500,000 | $0.09 | $135K | 1,738,792 |
| 2024-01-10 | GANDOLFO JOHN P Former Director | Returned to the company · Restricted Stock Unit (Right to Buy) | −1,500,000 | $0.09 | $135K | 0 |
| 2023-12-29 | Emerson Erik C. Chief Commerical Officer | Grant or award · Stock Option (Right to Buy) | +200,000 | $0.10 | $20K | 200,000 |
| 2023-12-29 | FARRELL CHRISTINE Chief Financial Officer | Grant or award · Stock Option (Right to Buy) | +500,000 | $0.10 | $50K | 500,000 |
| 2023-12-29 | REDMOND J MICHAEL President & CEO | Grant or award · Stock Option (Right to Buy) | +500,000 | $0.10 | $50K | 500,000 |
| 2023-12-29 | Gironda Gregory W Chief Operating Officer | Grant or award · Stock Option (Right to Buy) | +200,000 | $0.10 | $20K | 200,000 |
| 2023-12-29 | Casey Jerome H Director | Grant or award · Stock Option (Right to Buy) | +250,000 | $0.10 | $25K | 250,000 |
| 2023-12-29 | RICHARDSON RICKY Director | Grant or award · Stock Option (Right to Buy) | +250,000 | $0.10 | $25K | 250,000 |
| 2023-01-12 | RICHARDSON RICKY Director | Grant or award · Restricted Stock Unit (Right to Buy) | +500,000 | $0.30 | $150K | 1,000,000 |
| 2023-01-12 | REDMOND J MICHAEL President & CEO | Grant or award · Restricted Stock Unit (Right to Buy) | +100,000 | $0.30 | $30K | 3,100,000 |
| 2023-01-12 | REDMOND J MICHAEL President & CEO | Grant or award · Restricted Stock Unit (Right to Buy) | +400,000 | $0.30 | $120K | 3,500,000 |
| 2023-01-12 | GANDOLFO JOHN P Director | Grant or award · Restricted Stock Unit (Right to Buy) | +500,000 | $0.30 | $150K | 1,500,000 |
| 2023-01-12 | FARRELL CHRISTINE CFO | Grant or award · Restricted Stock Unit (Right to Buy) | +100,000 | $0.30 | $30K | 1,300,000 |
Page 1 of 3 · 50 trades